Analysis of DNA microarray expression data

Best Practice and Research: Clinical Haematology

Volumn 22, Issue 2, 2009, Pages 271-282

  Simon, Richard ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

bioinformatics; biomarkers; gene expression signatures; microarray data analysis

Indexed keywords

ANALYTIC METHOD; ARTICLE; BIOINFORMATICS; CLASSIFIER; CLINICAL RESEARCH; DATA ANALYSIS; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC IDENTIFICATION; MATHEMATICAL COMPUTING; PATIENT IDENTIFICATION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; SYSTEMATIC ERROR; VALIDATION PROCESS;

BIOMEDICAL RESEARCH; FLUORESCENCE; GENE EXPRESSION PROFILING; GENES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RESEARCH DESIGN; STATISTICS AS TOPIC; VALIDATION STUDIES AS TOPIC;

EID: 68749118357     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beha.2009.07.001     Document Type: Article

References (63)

1. Dupuy A., and Simon R. Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting. J Natl Cancer Inst 99 (2007) 147-157
2. Simon R., Lam A., Li M.C., et al. Analysis of gene expression data using BRB-ArrayTools. Cancer Inform 2 (2007) 11-17
3. Irizarry R.A., Wu Z., and Jaffee H.A. Comparison of Affymetrix GeneChip expression measures. Bioinformatics 22 7 (2006) 789-794
4. Bolstad B.M., Irizarry R.A., Astrand M., et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19 (2003) 185-193
5. Park T., Yi S.G., Kang S.H., et al. Evaluation of normalization methods for microarray data. BMC Bioinformatics 4 (2003) 33
6. Simon R., Radmacher M.D., Dobbin K., et al. Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J Natl Cancer Inst 95 (2003) 14-18
7. Simon R., Korn E.L., McShane L.M., et al. Design and analysis of DNA microarray investigations (2003), Springer Verlag, New York
8. Korn E.L., McShane L.M., Troendle J.F., et al. Identifying pre-post chemotherapy differences in gene expression in breast tumors: a statistical method appropriate for this aim. Br J Cancer 86 (2002) 1093-1096
9. Yang S.X., Simon R.M., Tan A.R., et al. Gene expression patterns and profile changes pre- and post-erlotinib treatment in patients with metastatic breast cancer. Clin Cancer Res 11 (2005) 6226-6232
10. Sotiriou C., Neo S.Y., McShane L.M., et al. Breast cancer classification and prognosis based on gene expression profiles from a population based study. Proc Natl Acad Sci U S A 100 18 (2003) 10393-10398
11. Desai K.V., Xiao N., Wang W., et al. Initiating oncogenic event determines gene-expression patterns of human breast cancer models. Proc Natl Acad Sci USA 99 (2002) 6967-6972
12. Simon R. Development and validation of therapeutically relevant multi-gene biomarker classifiers. J Natl Cancer Inst 97 (2005) 866-867
13. van'tVeer L.J., Dai H., Vijver M., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 (2002) 530-536
14. van-de-Vijver M.J., He Y.D., Veer L., et al. A gene expression signature as a predictor of survival in breast cancer. N Engl J Med 347 25 (2002) 1999-2009
15. Ma X.J., Wang Z., Ryan P.D., et al. A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 5 (2004) 1-10
16. Ayers M., Symmans W.F., Stec J., et al. Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer. J Clin Oncol 22 12 (2005) 2284-2293
17. Jansen M.P.H.M., Foekens J.A., Staveren I., et al. Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling. J Clin Oncol 23 4 (2005) 732-740
18. Perou C.M., Serlie T., Eisen M.B., et al. Molecular portraits of human breast tumors. Nature 406 (2000) 747-752
19. McShane L.M., Radmacher M.D., Freidlin B., et al. Methods of assessing reproducibility of clustering patterns observed in analyses of microarray data. Bioinformatics 18 (2002) 1462-1469
20. Klebanov L., and Yakovlev A. Is there an alternative to increasing the sample size in microarray studies?. Bioinformation 1 10 (2007) 429-431
21. Shih J.H., Michalowska A.M., Dobbin K., et al. Effects of pooling mRNA in microarray class comparison. Bioinformatics 20 (2004) 3318-3325
22. Dobbin K., Shih J., and Simon R. Questions and answers on design of dual-label microarrays for identifying differentially expressed genes. J Natl Cancer Inst 95 (2003) 1362-1369
23. Dobbin K., and Simon R. Sample size determination in microarray experiments for class comparison and prognostic classification. Biostatistics 6 (2005) 27-38
24. Dobbin K., and Simon R. Sample size planning for developing classifiers using high dimensional DNA expression data. Biostatistics 8 (2007) 101-117
25. Wright G.W., and Simon R. A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 19 (2003) 2448-2455
26. Baldi P., and Long A.D. A Bayesian framework for the analysis of microarray expression data: regularized t test and statistical inferences of gene changes. Bioinformatics 17 (2001) 509-519
27. Benjamini Y., and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B 57 (1995) 289-300
28. Korn E., Troendle J.F., McShane L.M., et al. Controlling the number of false discoveries: application to high-dimensional genomic data. J Stat Plan Inference 124 (2004) 379-398
29. Korn E.L., Li M.C., McShane L.M., et al. An investigation of SAM and the multivariate permutation test for controlling the false discovery proportion. Statistics in Medicine 26 (2007) 4428-4440
30. Subramanian A., Tamayo P., and Mootha V.K. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102 43 (2005) 15545-15550
31. Tian L., Greenberg S.A., Kong S.W., et al. Discovering statistically significant pathways in expression profiling studies. Proc Natl Acad Sci U S A 102 38 (2005) 13544-13549
32. Xu X., Zhao Y., and Simon R. Gene sets expression comparison in BRB-ArrayTools. Bioinformatics 24 (2008) 137-139
33. Storey J.D., Xiao W., Leek J.T., et al. Significance analysis of time course microarray experiments. Proc Natl Acad Sci U S A 102 (2005) 12837-12842
34. Leek J.T., Monsen E., Dabney A.R., et al. EDGE: extraction and analysis of differential gene expression. Bioinformatics 22 (2006) 507-508
35. Simon R. When is a genomic classifier ready for prime time?. Nat Clin Pract Oncol 1 1 (2004) 2-3
36. Radmacher M.D., McShane L.M., and Simon R. A paradigm for class prediction using gene expression profiles. J Comput Biol 9 (2002) 505-512
37. Dudoit S., and Fridlyand J. Classification in microarray experiments. In: Speed T. (Ed). Statistical analysis of gene expression microarray data (2003), Chapman & Hall/CRC, London, New York, Washington D.C.: Boca Raton;
38. Dudoit S., Fridlyand J., and Speed T.P. Comparison of discrimination methods for the classification of tumors using gene expression data. J Am Stat Assoc 97 (2002) 77-87
39. Golub T.R., Slonim D.K., Tamayo P., et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286 (1999) 531-537
40. Ramaswamy S., Tamayo P., Rifkin R., et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci U S A 98 (2001) 15149-15154
41. Ben-Dor A., Bruhn L., Friedman N., et al. Tissue classification with gene expression profiles. J Comput Biol 7 (2000) 559-584
42. Tibshirani R., Hastie T., Narasimhan B., et al. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A 99 (2002) 6567-6572
43. Bo T.H., and Jonassen I. New feature subset selection procedures for classification of expression profiles. Genome Biol 3 4 (2002) 0017.1-0017.11
44. Ooi C.H., and Tan P. Genetic algorithms applied to multi-class prediction for the analysis of gene expression data. Bioinformatics 19 (2003) 37-44
45. Deutsch J.M. Evolutionary algorithms for finding optimal gene sets in microarray prediction. Bioinformatics 19 (2003) 45-54
46. Kim S., Dougherty E.R., Barrera J., et al. Strong feature sets from small samples. J Comput Biol 9 (2002) 127-146
47. Lai C., Reinders M.J.T., Veer L., et al. A comparison of univariate and multivariate gene selection techniques for classification of cancer datasets. BMC Bioinformatics 7 (2006) 235
48. Lecocke M., and Hess K. An empirical study of univariate and genetic algorithm-based feature selection in binary classification with microarray data. Cancer Inform 2 (2006) 313-327
49. Dobbin K., Beer D.G., Meyerson M., et al. Inter-laboratory comparability study of cancer gene expression analysis using oligonucleotide microarrays. Clin Cancer Res 11 (2005) 565-572
50. Paik S., Shak S., Tang G., et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351 (2004) 2817-2826
51. Rosenwald A., Wright G., Chan W.C., et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346 (2002) 1937-1947
52. Michiels S., Koscielny S., and Hill C. Prediction of cancer outcome with microarrays: a multiple validation strategy. Lancet 365 (2005) 488-492
53. Molinaro A.M., Simon R., and Pfeiffer R.M. Prediction error estimation: a comparison of resampling methods. Bioinformatics 21 15 (2005) 3301-3307
54. Simon R., and Altman D.G. Statistical aspects of prognostic factor studies in oncology. Br J Cancer 69 (1994) 979-985
55. Bast R.C., Ravdin P., Hayes D.F., et al. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19 (2001) 1865-1878
56. Shipp M.A., Ross K.N., Tamayo P., et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 8 (2002) 68-74
57. Simon R. A roadmap for developing and validating therapeutically relevant genomic classifiers. J Clin Oncol 23 (2005) 7332-7341
58. Simon R., and Maitournam A. Evaluating the efficiency of targeted designs for randomized clinical trials. Clin Cancer Res 10 (2005) 6759-6763
59. Simon R. Using genomics in clinical trial design. Clin Cancer Res 14 (2008) 5984-5993
60. Sargent D.J., Conley B.A., and Allegra C. Clinical trial designs for predictive marker validation in cancer treatment trials. J Clin Oncol 23 9 (2005) 2020-2027
61. Pusztai L., and Hess K.R. Clinical trial design for microarray predictive marker discovery and assessment. Ann Oncol 15 (2004) 1731-1737
62. Bogaerts J., Cardoso F., Buyse M., et al. Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial. Nat Clin Pract Oncol 3 10 (2006) 540-551
63. Simon R., and Wang S.J. Use of genomic signatures in therapeutics development. Pharmacogenomics J 6 (2006) 166-173